Financial News
Latest News about NVO
Recent news which mentions NVO
Could Viking Therapeutics Become the Next Novo Nordisk?
August 17, 2024
From Motley Fool
Doctors Struggle to Secure Medicare Coverage for Heart Patients on Novo Nordisk's Wegovy
August 16, 2024
From Benzinga
Roche Misses Out On Weight-Loss Blockbuster Drug, Now Playing Catch-Up In Booming Market
August 16, 2024
From Benzinga
From Motley Fool
Unpacking the Latest Options Trading Trends in Novo Nordisk
August 15, 2024
Tickers
NVO
From Benzinga
Prediction: This Company Will Disrupt Eli Lilly and Novo Nordisk in the Weight Loss Market (Hint: It's Not Pfizer)
August 15, 2024
From Motley Fool
Tickers
NVO
From Motley Fool
Don't Promote Copycat Weight-Loss Drugs Amid Improved Supply, Eli Lilly Asks Doctors, FDA Evaluates
August 14, 2024
From Benzinga
Eli Lilly Smashed Estimates Thanks To Unbelievable Demand For Its Diabetes And Weight Loss Blockbusters
August 14, 2024
From Benzinga
3 Stable Blue-Chip Stocks to Buy for the Market Storm
August 14, 2024
From InvestorPlace
From Motley Fool
Tickers
NVO
From Motley Fool
From InvestorPlace
From Motley Fool
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
August 12, 2024
From Benzinga
Weight Loss Stocks Could Become Alzheimer's Drugs Stocks. Here's Why That's Bullish for Novo Nordisk
August 12, 2024
Tickers
NVO
From Motley Fool
Eli Lilly's Q2 Sales Surge 36%, Analysts Cautious On Future Supply, Market Dynamics; Optimistic About Next-Gen Oral Weight-Loss Drug
August 09, 2024
From Benzinga
From Motley Fool
Tickers
NVO
From Motley Fool
Here's Why Eli Lilly Stock Dropped 12% Last Month
August 08, 2024
From Motley Fool
Novo Nordisk Withdraws Wegovy FDA Heart Failure Submission, Terminates Development Of Two Early Stage Assets
August 07, 2024
From Benzinga
From Benzinga
Why Shares of Wegovy Maker Novo Nordisk Are Tumbling Today
August 07, 2024
Tickers
NVO
From Motley Fool
What's Going On With Eli Lilly And Company Shares Wednesday?
August 07, 2024
From Benzinga
Weight-Loss Giant Novo Nordisk Tumbles To 200-Day Average Support: 'Weakness Could Be Buying Opportunity,' Analyst Says
August 07, 2024
Tickers
NVO
From Benzinga
Ozempic-Maker Novo Nordisk Reveals Patients Stay On Wegovy Weight-Loss Drug For 6 Months Due To Low Availability
August 07, 2024
From Benzinga
Tickers
NVO
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
